AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BETHESDA, MD. -- Highly active antiretroviral therapy continues to cut the incidence of HIV-related cancers 5 years after its introduction into routine clinical practice, Dr. Anca M. Bulgaru said at an international conference on malignancies in AIDS and other immunodeficiencies.
Researchers noted a drop in the rate of HIV-related cancers immediately after highly active antiretroviral therapy (HAART) was introduced in 1996 but did not know whether that trend would continue. In a review of the experience at a single facility for an additional 5 years, Dr. Bulgaru reported that there has been no increase ...